Hannes Fiepko Koolman

This inventor holds 15 USPTO granted patents and 14 published patent applications and 6 EPO patents. Top assignees: Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Vetmedica Gmbh, Boehringer Ingelheim Animal Health USA Inc.. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hannes Fiepko Koolman. Retrieved from https://idiyas.com/inventor/hannes-fiepko-koolman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 14)

% Patents Active = 100.0

EPO Patents = 6 (Patent Applications = 15)

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 4(Granted Patents)

Location History:

Biberach, DE (2020 - 2022)
Biberach an der Riss, DE (2023 - 2024)

Company Filing History:

7 out of 1,564

Boehringer Ingelheim International Gmbh

patents

5 out of 317

Boehringer Ingelheim Vetmedica Gmbh

patents

1 out of 94

Boehringer Ingelheim Animal Health USA Inc.

patents

4. 1 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

patents

5. 1 out of 183

Nihon Nohyaku Co., Ltd.

patents

Years Active: 2020-2026

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12559503 - Anthelmintic aza-benzothiophene and aza-benzofuran compounds (2026-02-24),

2. 12503474 - Substituted pyrrolo[1,2-b]pyridazines as anthelmintics (2025-12-23),

3. 12435083 - Cyclopropyl-(hetero)aryl-substituted ethylsulphonyl-pyridine derivatives (2025-10-07),

4. 12391667 - N-methyl, n-(6-(methoxy)pyridazin-3-yl) amine derivatives as Autotaxin (ATX) modulators for the treatment of inflammatory airway or fibrotic diseases (2025-08-19),

5. 12358910 - Heteroaromatic compounds as Vanin inhibitors (2025-07-15),

6. 12312356 - Anthelmintic heterocyclic compounds (2025-05-27),

7. 12269822 - Anthelminthic heterocyclic compounds (2025-04-08),

8. 12240828 - Heteroaromatic compounds as vanin inhibitors (2025-03-04),

9. 11999742 - Substituted pyrrolo[1,2-b]pyridazines as anthelmintics (2024-06-04),

10. 11964977 - Anthelmintic heterocyclic compounds (2024-04-23),

11. 11560388 - Anthelmintic aza-benzothiophene and aza-benzofuran compounds (2023-01-24),

12. 11485727 - N-methyl, n-(6-(methoxy)pyridazin-3-yl) amine derivatives as autotaxin (ATX) modulators (2022-11-01),

13. 11465982 - Pyridazines (2022-10-11),

14. 11078182 - Heteroaromatic compounds as Vanin inhibitors (2021-08-03),

15. 10864201 - Heteroaromatic compounds as Vanin inhibitors (2020-12-15),

Title: The Innovative Journey of Hannes Fiepko Koolman

Introduction:

Hannes Fiepko Koolman, a distinguished inventor hailing from Biberach, Germany, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents:

Koolman's latest patents showcase his expertise in developing cutting-edge solutions for various industries, ranging from healthcare to renewable energy.

Career Highlights:

With a career spanning over two decades, Koolman has established himself as a visionary inventor with a keen eye for identifying gaps in the market and creating innovative solutions to address them. His passion for pushing the boundaries of technology has led to the successful commercialization of several of his inventions.

Collaborations:

Throughout his career, Koolman has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion:

In conclusion, Hannes Fiepko Koolman's relentless pursuit of innovation and his commitment to excellence have solidified his reputation as a trailblazer in the world of technology. His contributions continue to inspire the next generation of inventors to think outside the box and create solutions that have a lasting impact on society.

Profile summary based on public USPTO records.